Abstract:Cytokines constitute a class of secreted proteins that activate transmembrane receptors to coordinate a vast array of physiological processes, particularly those related to immune activity. Due to their vital role in immune regulation, cytokines have garnered great interest as potential therapeutic agents. Unfortunately, the clinical success of cytokine drugs has been limited by their multifunctional activities, which hinder therapeutic performance and lead to harmful toxicities. In addition, the strikingly short circulation half-life of cytokines further hampers their efficacy as drugs. To overcome the translational challenges associated with natural cytokines, significant efforts have focused on engineering cytokines to target their activities and improve their pharmacological properties. One such strategy is the design of fusion proteins that tether a cytokine to an anti-cytokine antibody that selectively biases its functions and extends its serum half-life. These cytokine/antibody fusion proteins (termed immunocytokines) assemble intramolecularly to bias cytokine signaling behavior through multi-layered structural and molecular effects. Here, we present a detailed workflow for the design, production, and functional validation of intramolecularly assembled immunocytokines. In-depth procedures are presented for gene manipulation, mammalian cell-based expression and purification, binding analysis via bio-layer interferometry, and interrogation of cytokine signaling activity on human primary cells. In contrast with immunocytokines in which the tethered cytokine and antibody do not bind one another, intramolecularly assembled immunocytokines require special considerations with respect to their production to avoid oligomerization and/or aggregation. The protocol herein was developed based on experience with immunocytokines that incorporate interleukin-2 (IL-2); however, this modular approach can be extended to any cytokine of interest for a broad range of biomedical applications. © 2024 Wiley Periodicals LLC. Basic Protocol 1: Design and generation of immunocytokine genes Basic Protocol 2: Immunocytokine expression and purification Basic Protocol 3: Validation of immunocytokine assembly and binding by bio-layer interferometry Basic Protocol 4: Analysis of immunocytokine signaling on human primary cells.

A strategy to design protein-based antagonists against type I cytokine receptors

Tuning of granulopoietic signaling by designed agonists

De novo design of miniprotein antagonists of cytokine storm inducers

Recent Progress in Capturing and Neutralizing Inflammatory Cytokines

A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors

Engineering Anticytokine Antibodies for Immune Modulation

Taming the beast: engineering strategies and biomedical potential of antibody-based cytokine mimetics

Taming the cytokine storm: small molecule inhibitors targeting IL-6/IL-6α receptor

Cytokine/Antibody Fusion Protein Design and Evaluation

Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds

Topological control of cytokine receptor signaling induces differential effects in hematopoiesis

Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress

Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity

Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5

Tuning Insulin Receptor Signaling Using De Novo Designed Agonists

De novo design of mini-binder proteins against IL-2 receptor β chain

Next-generation Cytokines for Cancer Immunotherapy.

Manipulation of Receptor Oligomerization As a Strategy to Inhibit Signaling by TNF Superfamily Members

Peptide therapeutic leads for multi-target inhibition of inflammatory cytokines in Inflammatory Bowel Disease - computational design and in-vitro validation

Rational Design of De Novo CCL2 Binding Peptides

Small-Molecule TLR8 Antagonists Via Structure-Based Rational Design.